{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:26:09Z","timestamp":1780590369429,"version":"3.54.1"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Autologous hematopoietic stem cell transplantation (autoHSCT) is increasingly being recognized as a treatment option for severe refractory autoimmune diseases (AD). However, efficacy is hampered by high relapse rates. In contrast, allogeneic HSCT (alloHSCT) has high potential to cure AD, but is associated with significant morbidity and mortality, and data in AD are limited. Experience with autoHSCT in relapsing polychondritis, a rare episodic inflammatory disorder characterized by destruction of cartilage, is scarce and alloHSCT has not been described before.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case Presentation<\/jats:title><jats:p>Here, we present a case of a 9-year-old girl who was diagnosed with relapsing polychondritis, with severe airway involvement requiring a tracheostomy. The disease proved to be steroid-dependent and refractory to a wide array of disease-modifying anti-rheumatic drugs and biologicals. After an autoHSCT procedure, the disease became inactive for a short period of time, until the patient experienced a relapse after 31 days, accompanied by repopulation of effector\/memory CD8<jats:sup>+<\/jats:sup> T cells. Because of persistent inflammation and serious steroid toxicity, including severe osteoporosis, growth restriction, and excessive weight gain, the patient was offered an alloHSCT. She experienced transient antibody-mediated immune events post-alloHSCT, which subsided after rituximab. She ultimately developed a balanced immune reconstitution and is currently still in long-term disease remission, 8 years after alloHSCT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This case adds to the few existing reports on autoHSCT in relapsing polychondritis and gives new insights in its pathogenesis, with a possible role for CD8<jats:sup>+<\/jats:sup> T cells. Moreover, it is the first report of successful alloHSCT as a treatment for children with this severe autoimmune disease.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.812927","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T10:38:22Z","timestamp":1646908702000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Case Report: Lessons Learned From Subsequent Autologous and Allogeneic Hematopoietic Stem Cell Transplantations in a Pediatric Patient With Relapsing Polychondritis"],"prefix":"10.3389","volume":"13","author":[{"given":"Saskia R.","family":"Veldkamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc H. A.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost F.","family":"Swart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline A.","family":"Lindemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.7","article-title":"Haematopoietic Stem Cell Transplantation for Autoimmune Diseases","volume":"13","author":"Swart","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000823","article-title":"Haematopoietic Stem Cell Transplantation in Paediatric Rheumatic Disease","volume":"33","author":"Abinun","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-070119-115617","article-title":"Hematopoietic Stem Cell Transplantation for Autoimmune Disease","volume":"72","author":"Alexander","year":"2021","journal-title":"Annu Rev Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30169-6","article-title":"Immunoablation and Autologous Haemopoietic Stem-Cell Transplantation for Aggressive Multiple Sclerosis: A Multicentre Single-Group Phase 2 Trial","volume":"388","author":"Atkins","year":"2016","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis: A Randomized Clinical Trial","volume":"311","author":"van Laar","year":"2014","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S2468-1253(17)30056-0","article-title":"Autologous Stem-Cell Transplantation in Treatment-Refractory Crohn\u2019s Disease: An Analysis of Pooled Data From the ASTIC Trial","volume":"2","author":"Lindsay","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.013458","article-title":"Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: An Observational Study on 12 Years\u2019 Experience From the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases","volume":"95","author":"Dominique","year":"2010","journal-title":"Haematologica"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01570","article-title":"Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working Parties","volume":"10","author":"Greco","year":"2019","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017010041","article-title":"Evolution, Trends, Outcomes, and Economics of Hematopoietic Stem Cell Transplantation in Severe Autoimmune Diseases","volume":"1","author":"Snowden","year":"2017","journal-title":"Blood Adv"},{"key":"B10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/life11030258","article-title":"The Effect of Tocilizumab on Inflammatory Markers in Patients Hospitalized With Serious Infections. Case Series and Review of Literature","volume":"11","author":"Berman","year":"2021","journal-title":"Life"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-06-721936","article-title":"Excellent T-Cell Reconstitution and Survival Depend on Low ATG Exposure After Pediatric Cord Blood Transplantation","volume":"128","author":"Admiraal","year":"2016","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(15)00045-9","article-title":"Association Between Anti-Thymocyte Globulin Exposure and CD4+ Immune Reconstitution in Paediatric Haemopoietic Cell Transplantation: A Multicentre, Retrospective Pharmacodynamic Cohort Analysis","volume":"2","author":"Admiraal","year":"2015","journal-title":"Lancet Haematol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s002960000055","article-title":"Relapsing Polychondritis in Childhood \u2013 Case Report and Short Review","volume":"19","author":"Knipp","year":"2000","journal-title":"Rheumatol Int"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-2336-6","article-title":"Relapsing Polychondritis in Childhood: Three Case Reports, Comparison With Adulthood Disease and Literature Review","volume":"33","author":"Fonseca","year":"2013","journal-title":"Rheumatol Int"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex406","article-title":"Relapsing Polychondritis: A Clinical Review for Rheumatologists","volume":"57","author":"Kingdon","year":"2017","journal-title":"Rheumatology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212705","article-title":"Efficacy and Safety of Biologics in Relapsing Polychondritis: A French National Multicentre Study","volume":"77","author":"Moulis","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/ar107","article-title":"Autologous Stem-Cell Transplantation in Refractory Autoimmune Diseases After In Vivo Immunoablation and Ex Vivo Depletion of Mononuclear Cells","volume":"2","author":"Rosen","year":"2000","journal-title":"Arthritis Res Ther"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.056630","article-title":"Haematopoietic Stem Cell Transplantation for Vasculitis Including Beh\u00e7et\u2019s Disease and Polychondritis: A Retrospective Analysis of Patients Recorded in the European Bone Marrow Transplantation and European League Against Rheumatism Databases and a Review of the Literature","volume":"66","author":"Daikeler","year":"2007","journal-title":"Ann Rheumatic Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/art.24366","article-title":"Treatment of Relapsing Polychondritis With Rituximab: A Retrospective Study of Nine Patients","volume":"61","author":"Leroux","year":"2009","journal-title":"Arthritis Care Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11926-015-0549-5","article-title":"Relapsing Polychondritis: An Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives","volume":"18","author":"Vitale","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"B21","first-page":"96","article-title":"Relapsing Polychondritis: Clinical and Immunogenetic Analysis of 62 Patients","volume":"24","author":"Zeuner","year":"1997","journal-title":"J\u00a0Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.101044","article-title":"Cartilage Destruction Is Partly Induced by the Internal Proteolytic Enzymes and Apoptotic Phenomenon of Chondrocytes in Relapsing Polychondritis","volume":"38","author":"Ouchi","year":"2011","journal-title":"J Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.52.9080","article-title":"Relapsing Polychondritis Complicated by Giant Cell Myocarditis and\u00a0Myositis","volume":"52","author":"Watanabe","year":"2013","journal-title":"Internal Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200201)46:1<238::AID-ART10030>3.0.CO;2-M","article-title":"Identification of Type II Collagen Peptide 261\u2013273-Specific T Cell Clones in a Patient With Relapsing Polychondritis","volume":"46","author":"Buckner","year":"2002","journal-title":"Arthritis Rheum"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-eular.1250","article-title":"SAT0018 The Study of Cd4+t Cell Subsets In Recurrent Polychondritis","volume":"78","author":"Hu","year":"2019","journal-title":"Ann Rheumatic Dis"},{"key":"B26","article-title":"T-Cell Receptor (TCR) Sequencing Reveals Decreased Diversity and Clonotypic Expansion of T-Cells in Relapsing Polychondritis (RP) [Abstract]","volume":"72","author":"Rominger E","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197811302992202","article-title":"Antibodies to Type II Collagen in Relapsing Polychondritis","volume":"299","author":"Foidart","year":"1978","journal-title":"New Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/BF00371591","article-title":"Autoantibodies to Cartilage Collagens in Relapsing Polychondritis","volume":"285","author":"Yang","year":"1993","journal-title":"Arch Dermatol Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00767","article-title":"Resetting the T Cell Compartment in Autoimmune Diseases With Autologous Hematopoietic Stem Cell Transplantation: An Update","volume":"9","author":"Lutter","year":"2018","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1182\/blood-2015-06-649145","article-title":"Autologous Stem Cell Transplantation Aids Autoimmune Patients by Functional Renewal and TCR Diversification of Regulatory T Cells","volume":"127","author":"Delemarre","year":"2016","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-12-128488","article-title":"Autologous Bone Marrow Transplantation in Autoimmune Arthritis Restores Immune Homeostasis Through CD4+CD25+Foxp3+ Regulatory T Cells","volume":"111","author":"Roord","year":"2008","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703831","article-title":"Rapid Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation in Children: A Single Institution Experience","volume":"31","author":"Hoepfner","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.2.754.014k39_754_762","article-title":"Prolonged CD4 Depletion After Sequential Autologous Peripheral Blood Progenitor Cell Infusions in Children and Young Adults","volume":"96","author":"Mackall","year":"2000","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001340","article-title":"Comparison of Immune Reconstitution After Allogeneic Versus Autologous Stem Cell Transplantation in 182 Pediatric Recipients","volume":"41","author":"Wiegering","year":"2019","journal-title":"J Pediatr Rheumatol Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(11)62388-4","article-title":"Immune Reconstitution After Autologous Hematopoietic Stem Cell Transplantation","volume":"76","author":"Porrata","year":"2001","journal-title":"Mayo Clinic Proc"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI71691","article-title":"T Cell Repertoire Following Autologous Stem Cell Transplantation for Multiple Sclerosis","volume":"124","author":"Muraro","year":"2014","journal-title":"J Clin Invest"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq414","article-title":"Analysis of Immune Reconstitution After Autologous CD34+ Stem\/Progenitor Cell Transplantation for Systemic Sclerosis: Predominant Reconstitution of Th1 CD4+ T Cells","volume":"50","author":"Tsukamoto","year":"2010","journal-title":"Rheumatology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/art.21036","article-title":"Analysis of Immune Reconstitution After Autologous Bone Marrow Transplantation in Systemic Sclerosis","volume":"52","author":"Farge","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.139","article-title":"T-Cell Clones Persisting in the Circulation After Autologous Hematopoietic SCT Are Undetectable in the Peripheral CD34+ Selected Graft","volume":"45","author":"Dubinsky","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041679","article-title":"Thymic Output Generates a New and Diverse TCR Repertoire After Autologous Stem Cell Transplantation in Multiple Sclerosis Patients","volume":"201","author":"Muraro","year":"2005","journal-title":"J Exp Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-168286","article-title":"Depletion of Autoreactive Immunologic Memory Followed by Autologous Hematopoietic Stem Cell Transplantation in Patients With Refractory SLE Induces Long-Term Remission Through De Novo Generation of a Juvenile and Tolerant Immune System","volume":"113","author":"Alexander","year":"2009","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1093\/brain\/awh117","article-title":"Characteristics of T-Cell Receptor Repertoire and Myelin-Reactive T Cells Reconstituted From Autologous Haematopoietic Stem-Cell Grafts in Multiple Sclerosis","volume":"127","author":"Sun","year":"2004","journal-title":"Brain"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e31887","DOI":"10.1371\/journal.pone.0031887","article-title":"Acute Response of Peripheral Blood Cell to Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetic Patient","volume":"7","author":"Zhang","year":"2012","journal-title":"PloS One"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23784","article-title":"Diminished Th17 (Not Th1) Responses Underlie Multiple Sclerosis Disease Abrogation After Hematopoietic Stem Cell Transplantation","volume":"73","author":"Darlington","year":"2013","journal-title":"Ann Neurol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-07-2800","article-title":"Autologous Stem Cell Transplantation for Autoimmunity Induces Immunologic Self-Tolerance by Reprogramming Autoreactive T Cells and Restoring the CD4+CD25+ Immune Regulatory Network","volume":"107","author":"de Kleer","year":"2006","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901773","article-title":"Regulatory T Cell (Treg) Subsets Return in Patients With Refractory Lupus Following Stem Cell Transplantation, and TGF-\u03b2-Producing CD8+ Treg Cells Are Associated With Immunological Remission of Lupus","volume":"183","author":"Zhang","year":"2009","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.clim.2016.06.005","article-title":"Immunological Correlates of Favorable Long-Term Clinical Outcome in Multiple Sclerosis Patients After Autologous Hematopoietic Stem Cell Transplantation","volume":"169","author":"Arruda","year":"2016","journal-title":"Clin Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.retram.2016.03.004","article-title":"Resetting the Immune Response After Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases","volume":"64","author":"Arruda","year":"2016","journal-title":"Curr Res Trans Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.12.6500","article-title":"Reversible Disruption of Thymic Function by Steroid Treatment","volume":"168","author":"Kong","year":"2002","journal-title":"J Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900225","article-title":"Ablation and Regeneration of Tolerance-Inducing Medullary Thymic Epithelial Cells After Cyclosporine, Cyclophosphamide, and Dexamethasone Treatment","volume":"183","author":"Fletcher","year":"2009","journal-title":"J Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01341","article-title":"Evaluating Thymic Function After Human Hematopoietic Stem Cell Transplantation in the Personalized Medicine Era","volume":"11","author":"Gaballa","year":"2020","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01745","article-title":"When the Damage Is Done: Injury and Repair in Thymus Function","volume":"11","author":"Kinsella","year":"2020","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-07-659672","article-title":"Alemtuzumab Levels Impact Acute GVHD, Mixed Chimerism, and Lymphocyte Recovery Following Alemtuzumab, Fludarabine, and Melphalan RIC HCT","volume":"127","author":"Marsh","year":"2016","journal-title":"Blood"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/art.22656","article-title":"Autologous Stem Cell Transplantation in Children With Severe Progressive Systemic or Polyarticular Juvenile Idiopathic Arthritis: Long-Term Followup of a Prospective Clinical Trial","volume":"56","author":"Brinkman","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2019.1656526","article-title":"The Rise of Autologous HCT for Autoimmune Diseases: What Is Behind It and What Does It Mean for the Future of Treatment? An Update on Behalf of the EBMT Autoimmune Diseases Working Party","volume":"15","author":"Snowden","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1080\/08916930802197677","article-title":"Allogeneic Hematopoietic Stem Cell Transplantation for Severe Autoimmune Diseases","volume":"41","author":"Gratwohl","year":"2008","journal-title":"Autoimmunity"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199803)41:3<453::AID-ART11>3.0.CO;2-#","article-title":"Long-Term Outcome of Autoimmune Disease Following Allogeneic Bone Marrow Transplantation","volume":"41","author":"Snowden","year":"1998","journal-title":"Arthritis Rheum"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703686","article-title":"Clinically Demonstrable Anti-Autoimmunity Mediated by Allogeneic Immune Cells Favorably Affects Outcome After Stem Cell Transplantation in Human Autoimmune Diseases","volume":"30","author":"Hinterberger","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70349-2","article-title":"Reduced-Intensity Conditioning Versus Standard Conditioning Before Allogeneic Haemopoietic Cell Transplantation in Patients With Acute Myeloid Leukaemia in First Complete Remission: A Prospective, Open-Label Randomised Phase 3 Trial","volume":"13","author":"Bornh\u00e4user","year":"2012","journal-title":"Lancet Oncol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(16)30114-4","article-title":"Association of Busulfan Exposure With Survival and Toxicity After Haemopoietic Cell Transplantation in Children and Young Adults: A Multicentre, Retrospective Cohort Analysis","volume":"3","author":"Bartelink","year":"2016","journal-title":"Lancet Haematol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2020.1831382","article-title":"Reducing Infectious Complications After Allogeneic Stem Cell Transplant","volume":"13","author":"Bacigalupo","year":"2020","journal-title":"Expert Rev Hematol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-019-0306-7","article-title":"Allogeneic HSCT for Autoimmune Disease: A Shared Decision","volume":"15","author":"Sullivan","year":"2019","journal-title":"Nat Rev Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.812927\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T10:38:27Z","timestamp":1646908707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.812927\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":62,"alternative-id":["10.3389\/fimmu.2022.812927"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.812927","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]},"article-number":"812927"}}